SFX by Ex Libris Inc.

Title:	The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response
Source:	Clinical Pharmacology & Therapeutics [0009-9236] Giacomini, K M yr:2007

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Huang, Y. "Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy." Cancer and metastasis reviews 26.1 (2007): 183-201.
description	2.	Sacks, F M M. "The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators." The New England journal of medicine 335.14 (1996): 1001-9.
description	3.	Baron, M. "Readers' responses and authors' reply to "medical marijuana: politics trumps science at the FDA"." MedGenMed 8.3 (2006): 79-.
description	4.	Piquette-Miller M, M. "The art and science of personalized medicine." Clinical pharmacology and therapeutics 81.3 (2007): 311-5.
description	5.	Shastry, Barkur S. "SNPs in disease gene mapping, medicinal drug development and evolution." Journal of human genetics 52.11 (2007): 871-880.
description	6.	Brands, P. "Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group." The New England journal of medicine 339.19 (1998): 1349-57.
description	7.	Innocenti, F.. "Challenges in the development and use of pharmacogenomic markers in oncology." The Journal of supportive oncology 5.1 (2007): 15-16.
description	8.	Abraham, J. "Pharmacogenetics of cancer chemotherapy." Biochimica et biophysica acta 1766.2 (2007): 168-83.
description	9.	Brands, S. "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)." The lancet 344.8934 (1994): 1383-9.
description	10.	Carter, Gregory T T. "Medical marijuana: politics trumps science at the FDA." MedGenMed 8.2 (2006): 46-.
description	11.	Shepherd, J. "Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group." The New England journal of medicine 333.20: 1301-1307.
description	12.	Rudolph, J. "Cdc25 phosphatases: Structure, specificity, and mechanism." Biochemistry 46.12 (2007): 3595-3604.
description	13.	Huang, Y. "Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells." Cancer letters 239.2 (2006): 168-182.
description	14.	Siegmund, W. "Disposition of the cholesterol absorption inhibitor ezetimibe in mdr1a/b (-/-) mice." Journal of pharmaceutical sciences (2008): 3478-84.
description	15.	Scandinavian, Simvastation Survival Study Group. "Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)." The lancet 345.896 (1995): 1274-5.
description	16.	Kim, S.. "SNP genotyping: Technologies and biomedical applications." Annual review of biomedical engineering 9.1 (2007): 289-320.
description	17.	anonymous. "Pain relief. Study rearms group challenging feds on medical marijuana." AIDS policy & law 22.5 (2007): 5-5.
description	18.	Ruden, Douglas M M. "Personalized medicine and quantitative trait transcripts." Nature genetics 39.2 (2007): 144-5.
description	19.	Lesko, L J J. "Personalized medicine: elusive dream or imminent reality?" Clinical pharmacology and therapeutics 81.6 (2007): 807-16.
description	20.	Griffing, George T T. "Endocannabinoids -- the Brain's Own Marijuana -- May Be Linked to the Metabolic Syndrome." MedGenMed 8.4 (2006): 7-.